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http://www.biomedcentral.com/1471-2458/14/952RESEARCH ARTICLE Open AccessThe effectiveness of the Allen Carr smoking
cessation training in companies tested in a
quasi-experimental design
Arie Dijkstra1*, Rixt Zuidema2, Diederick Vos3 and Marike van Kalken4Abstract
Background: The Allen Carr training (ACt) is a popular one-session smoking cessation group training that is
provided by licensed organizations that have the permission to use the Allen Carr method. However, few data are
available on the effectiveness of the training.
Methods: In a quasi-experimental design the effects of the existing practice of providing the ACt to smokers
(n = 124) in companies on abstinence, were compared to changes in abstinence in a cohort of similar smokers in
the general population (n = 161). To increase comparability of the smokers in both conditions, smokers in the
control condition were matched on the group level on baseline characteristics (fourteen variables) to the smokers
in the ACt. The main outcome measure was self-reported continuous abstinence after 13 months, which was
validated using a CO measurement in the Act condition.
Results: Logistic regression analyses showed that when baseline characteristics were comparable, significantly
more responding smokers were continuously abstinent in the ACt condition compared to the control condition,
Exp(B) = 6.52 (41.1% and 9.6%, respectively). The all-cases analysis was also significant, Exp(B) = 5.09 (31.5% and
8.3%, respectively).
Conclusion: Smokers following the ACt in their company were about 6 times more likely to be abstinent, assessed
after 13 months, compared to similar smokers in the general population. Although smokers in both conditions did
not differ significantly on 14 variables that might be related to cessation success, the quasi-experimental design
allows no definite conclusion about the effectiveness of the ACt. Still, these data support the provision of the ACt
in companies.
Keywords: Smoking cessation, Allen Carr training, Quasi-experimental, CO validationBackground
Allen Carr’s “Easyway to Stop Smoking training” (ACt)
is an one-session smoking cessation group training that
is provided by licensed organizations that have the per-
mission to use the Allen Carr method. The method also
has been published widely in book form. The Allen Carr
website states they have: “… sold over 10 million stop
smoking books in 57 countries in more than 38 languages
[…] Every year Allen Carr’s Easyway To Stop Smoking
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unless otherwise stated.50,000 smokers. There are stop smoking seminars in more
than 150 cities in over 45 countries worldwide” [1] In the
Netherlands, the licensee holder of the ACt primarily pro-
vides the training through companies, exposing about
1,500 smokers to it each year.
However, few data are available on the effectiveness of
the training. Only percentages of abstinence from co-
horts of smokers who followed the training are pub-
lished. One study [2] reported that of 357 smokers
exposed to the ACt in a company, at least 40% reported
point-prevalence abstinence after 12 months, while in
the cohort study [3] (N = 510) 51% of the smokers
reported abstinence about 3 three years after the ACt.
Two other studies in AC smoking cessation clinicsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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though the ACt seems widely used, very limited evidence
is available with regard to its effectiveness.
The best scientific design to test whether the ACt
method incorporates effective ingredients is the RCT. For
example, recruited smokers might be randomly assigned
to an ACt condition or to a no-intervention control condi-
tion. However, this is not always possible. In the present
study we aimed to assess whether providing the ACt to
smokers in companies is effective in stimulating ab-
stinence from smoking. This implies that the test of ef-
fectiveness must be conducted within the setting of the
companies, taking into account the demands and desires
of companies that join the study. For example, once com-
panies are interested in the ACt, they want to be certain
that they can offer the ACt to their smokers, and they find
it less desirable to let their smokers be randomized or to
be randomized as a (department of) a company to the
ACt condition or a control condition. Therefore, we tested
the ACt in companies in a quasi-experiment [5]. In a
quasi-experiment the practice of the ACt is monitored
and the changes are compared to the changes in an inde-
pendently recruited cohort of smokers, implying that no
randomization took place. Therefore, the quality of such a
quasi-experimental design primarily depends on the base-
line similarity on relevant variables of the participants in
the ACt group and those in the control group. Therefore,
in the present study, the most important demographic
variables (e.g., age, gender), smoking behavior related vari-
ables (e.g., FTND), and psychological variables (motivation
to quit, self-efficacy) were assessed at pretest to test and
shape the similarity.
The composition of the control group further deter-
mines the exact research question the quasi-experiment
will address. In the present study of ACt in companies,
an independent control group might be recruited from
other (similar) companies but also from the general
population. When the control group is recruited from
other companies, the design will show whether it is fruit-
ful to expose smokers in companies “to the ACt”. When
the control group is recruited from the general popula-
tion, the design will show whether it is fruitful to expose
smokers “in companies to the ACt”. Thus, in this case
the treatment package is “ACt in companies”. This is
what the present study is about: A quasi-experiment in
which smoking employees in companies are exposed
to the ACt, while their abstinence rate assessed after
13 months is compared to that of baseline-matched
smokers recruited from the general population.
Methods
Recruitment
The company “Bewegen Werkt” [Exercise Works] markets
the ACt in companies. Participants in the experimentalgroup were recruited between January 2011 and May
2012 through companies that decided to purchase the
ACt for their smoking employees. Smokers could follow
the training for free. Smokers were first informed by their
Human Resource department about an informative ses-
sion preceding the actual ACt that was going to take place.
This informative session was about the ACt but it was also
mentioned that some scientific measurements would take
place. At the end of this session interested smokers could
leave their contact information. They were then assigned
to an ACt trainer who was given access to the e-mail ad-
dresses of the smokers. These addresses were used by the
researchers to approach the smokers about two weeks
before the ACt was given. This e-mail emphasized that
their participation in the study was voluntary and that
they could withdraw from the study at any time without
penalty. In the e-mail the (three) measurements were
announced. About one week after they received this infor-
mation e-mail, another e- mail with the link to the base-
line (pretest) on-line questionnaire (T1) was sent.
Participants in the control group were recruited bet-
ween January 2011 and April 2012 through general mass-
media and social media throughout the Netherlands.
Advertisements, presented to over 100 regional newspa-
pers (no records were kept on actual ad placements) and
to social media, invited smokers “who wanted to quit” to
join a study on smoking and smoking cessation that would
consist of filling out three times an on-line questionnaire.
Interested smokers could e-mail to the address mentioned
in the advertisement and they were subsequently sent an
information e-mail with the same information as the
smokers in the experimental group received. One week
after that, an e-mail with the link to the baseline on-line
questionnaire (T1) was sent.
Procedure
Via an informed consent option in the online question-
naire, participants gave their permission for participation.
Participants in both conditions were not informed about
the existence of the other condition, only about their own
condition. Between January 2011 and May 2013 we sent
three times an e-mail with a link to an online question-
naire. The baseline questionnaire (T1) was sent about one
week before the ACt started. The follow-up questionnaires
were sent 2 weeks after the training took place (T2) and
13 months after T2 (T3). In the control group, smokers
received the T2 and T3 on-line questionnaires, 2 weeks
and 14 months after T1, respectively. Except for the T1
measurement in the experimental group, three reminder
e-mails were sent concerning each measurement: One
after three days, one after a week and the final one after
two weeks. To schedule the CO-measurement, the partici-
pants in the experimental condition who reported on T3
to be abstinent were contacted. It was tried to schedule
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pants filled in the T3 questionnaire.
Financial compensation was offered to lower dropout
rates. Participants were informed in the first e-mail that
they would earn 12.50 euros when they filled in the T1
measurement and another 20 euros when they would
complete the study by also filling out the T3 measure-
ment. In the mail on scheduling the CO-measurement,
participants were also informed that they would receive
20 euros, whatever the result of the test was. The re-
search was approved by the Ethical Committee Psy-
chology of the University of Groningen.
Allen Carr’s Easyway to Stop Smoking training
The ACt consisted of a one-meeting training including 5
to 8 smokers led by a trainer who was an ex-smoker.
Trainers are trained to provide the ACt, following a
loosely protocolled scheme in which they provide the
trainees subsequently with different questions and an-
swers (the Allen Carr manual containing the protocol
has not been made publicly available by the license
holder). When analyzing the content of the training, the
following working mechanisms can be recognized: The
core of the argument to quit smoking is that smoking
tobacco has no real benefits; it is only smoking away
withdrawal symptoms in an addicted body. From this
premise it follows that when the body is no longer
addicted, smoking has no beneficial effects whatsoever.
This core idea is repeated in different words using dif-
ferent analogues. Beliefs and experiences of the trainees
regarding the benefits of smoking are restructured and
challenged against the background of this notion. The
aim is to make the smokers completely endorse the core
idea, thereby fundamentally changing their perspective
on their smoking behavior, including reappraising their
past experiences with smoking. This restructuring of the
beliefs on the benefits of smoking can be conceptualized
as an expectancy challenge, as is applied to lower alcohol
consumption in several studies [6-8]. In smoking cessa-
tion, very few data are available on the effects of expec-
tancy challenge [9,10]. Besides the expectancy challenge,
other potential working mechanisms can be recognized
in the ACt. One effect of lowering the perceived benefits
of smoking is that the task of smoking cessation be-
comes easier. This may lead to a relative increase in self-
efficacy expectations, which is a reliable predictor of
abstinence [11,12]. Furthermore, the trainer always is an
ex-smoker, which makes him a model. In addition, the
group process may support a climate of change. Impor-
tantly, in the ACt protocol there is no explicit room for
motivating the trainees to quit. From the protocol and
from observation it seems that the only motivating infor-
mation in the training comes from the positive feelings
that are associated with no longer feeling addicted andhaving to smoke, and taking control over one’s life.
Thus, the ACt does not try to motivate smokers to quit,
it rather tries to lower the motivation to smoke.
After the training, participants were in the opportunity
to call their trainer by telephone for support to stay
abstinent. Furthermore, they could visit a follow-up
training (on their own initiative) for free in the year after
their training. As this was part of the package of the
ACt, no data were gathered on the use of these facilities.
Biochemical validation
To validate the self-reported abstinence, a CO-measure-
ment was conducted among respondents who indicated
to be abstinent at T3. These T3 respondents were con-
tacted by mail to make an appointment. The researchers
would visit the company site and conduct the CO-
measurement. This measurement was protocolled to
take place in a sitting position, in a private room after
the T3 abstinence was verified again by self-report.
When the CO-measurement indicated a higher than ex-
pected CO-level, some additional questions were asked
to check the reasons for the high level. The CO-level
was considered to verify the report of abstinence when it
was below 10 ppm, and when it was 10 ppm or higher it
was considered to falsify the abstinence [13]. The CO-
measure apparatus was the piCO + Smokerlyzer®. Before
the measurements started, the apparatus was calibrated
by the company from which it was purchased.
Measures
The baseline questionnaire consisted of different chap-
ters. Firstly, demographics were assessed: gender, age,
and level of education. Secondly, smoking behavior was
assessed with a question on the number of cigarettes
smoked a day, and another five questions that together
comprise the FTND test. [14] Thirdly, the baseline ques-
tionnaire contained measures regarding the psychology
of smoking and quitting smoking: The pros of quitting,
the pros of smoking and self-efficacy expectations.
The pros of quitting assess the motivation to quit. They
refer to the reasons for smokers to quit and because they
are related to personally valued outcomes they provide the
energizing power that underlies behavior change. The pros
of quitting were assessed using four short scales of each
three items on the following topics: The expectations con-
cerning positive long-term physical consequences of quit-
ting (e.g., “Quitting lowers my risk for lung cancer”),
expectations concerning positive short-term physical con-
sequences of quitting (e.g., “Quitting increases my physical
stamina”), expectations concerning positive social conse-
quences of quitting (e.g., “Quitting makes me a better
model for others”), and expectations concerning the
positive self-evaluative consequences of quitting (e.g.,
“Quitting makes me feel better about myself”). The scales
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tempts (during 9, 7, and 6 months intervals) in three inde-
pendent samples of smokers [14]. The items were in the
following format: “Quitting smoking [leads to the positive
consequence] ....”, and could be scored from “not sure” or
“not expecting a certain outcome” (0) to a “strong expec-
tation of the outcome” (3). The mean item scores were
used as the scale scores. The Cronbach’s α’s of the four
scales were .88, .64, .71, and .69, respectively.
The pros of smoking assess the motivation to smoke
or the level of “psychological addiction”. They refer to
the reasons to smoke; the expectation that smoking will
have specific valued effects. The pros of smoking were
assessed using a 9 item scale on the cognitive functions
of smoking, such as weight regulation, relaxation, and
coping with anger, and a 5 item scale on the positive
affective experiences of smoking, for example, satisfying,
likable and pleasant. The items of the first scale were
validated in earlier studies [15,16]. The second scale was
developed for this study. The items were in the following
format: “Smoking helps to/Smoking is to me ....”, and
could be scored on a 5-point scale with the options:
“completely disagree” (1), “disagree a little” (2), “not dis-
agree/not agree” (3), “agree a little” (4), “completely
agree” (5). The mean item scores were used as the scale
scores (Cognitive pros α = .80; affective pros α = .82).
Self-efficacy expectations assess the confidence smokers
have that they are able to remain abstinent. This confi-
dence determines the effort and persistence smokers in-
vest in their smoking cessation. Self-efficacy expectations
were assessed using three short scales that were validated
in earlier studies [17,18]. The items assessed the level of
confidence of each participant in his or her ability to re-
frain from smoking in emotional (“When you feel angry”),
social (“When you are offered a cigarette”), and habitual
(“After diner”) situations. All items were measured on a
7-point scale and could be scored from “not at all sure
I am able to” (−3) to “very sure I am able to” (+3). The
mean item scores were used as the scale scores. The α’s of
the three scales were .92, .87, and .86, respectively.
Because we do not report data from the first posttest
questionnaire (T2) that was administered three weeks
after the first one, this measurement will not be pre-
sented here.
The second posttest questionnaire (T3) was adminis-
tered 14 months after the pretest and it assessed smo-
king behavior since the ACt (in the experimental group)
or since the first posttest (in the control group). In the
experimental group, self-report abstinence was assessed
with two subsequent questions. The first abstinence
question was: “Did you quit smoking immediately after
the ACt?” The answering categories were: “Yes, and I
still do not smoke”; “Yes, but later I started smoking
again”; “No”; “I do not remember”. When respondentschose the first option, they were assumed to be conti-
nuous abstinent according to their self-report. When re-
spondents in the experimental group chose another
option, they were routed to the second abstinence ques-
tion: “Have you been smoking since the second mea-
surement about 13 months ago (even one cigarette)?”,
“Yes”/”No”. In the control group this question was the
primary abstinence question. Respondents who answered
“No” were considered continuous abstinent according to
their self-report. Respondents who answered this question
with “Yes” were asked subsequent questions on their
smoking behavior during the past 13 months.
The use of smoking cessation support since the second
measurement (which was administered three weeks after
the baseline measurement) was assessed with one categor-
ical question: Respondents could score one category from
the following six: 1. nicotine replacement/pharmacological
support of any kind; 2. (individual) counseling/coaching
(including e.g. acupuncture or support from the GP);
3. self-help materials; 4. nicotine replacement/pharmaco-




In the experimental group a total of 137 smokers in 15
companies in 19 training groups were trained. Of these
smokers who were all invited to join the study, 124 filled
in the T1 measurement. Of these T1 respondents, 95
also filled in the T3 measurement. Of the 183 smokers
in the control group who expressed interest to join the
study, 161 filled in the T1 measurement. Of these T1 re-
spondents, 137 also filled in the T3 measurement (see
Figure 1).
Thus, the baseline questionnaire was filled in by 285
smokers (124 in the ACt condition, 161 in the control
condition). Of these smokers, 232 also provided long
term data (81.4%), leaving 95 in the ACt condition
(76.6%) and 137 in the control condition (85%). A Chi-
square test on these drop out percentages showed a
trend towards a significant difference (Pearson’s Chi-
square p = .068).
In an attrition analysis, smokers who did not fill in the
T3 questionnaire (drop outs) were compared to those
who did fill in the T3 measurement on 14 variables: gen-
der, level of education, age, number of cigarettes smoked
a day, FTND score, the pros of quitting (four scales), the
pros of smoking (two scales), and self-efficacy (three
scales). Univariate analyses of variance on the conti-
nuous variables showed that those who dropped out,
firstly, scored significantly higher on physical depen-
dence (FTND), F(283,1) = 4.71, p = .031; respondents
M = 3.83 (SD = 2.28) versus drop outs M = 4.59 (2.3).
Secondly, drop outs scored significantly lower on self-
Figure 1 The attrition figures in the two conditions in the quasiexperimental design.
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respondents M = 4.31 (SD = 1.36) versus drop outs
M= 3.89 (1.32). For the two categorical variables, gender
and level of education, the Chi-square analyses showed that
drop outs did not differ significantly from respondents.
Smoking cessation support
Of the 208 respondents who answered the T3 question
about smoking cessation support since the second mea-
surement, 20 stated to have used nicotine replacement/
pharmacological support of any kind, 11 had received
counseling/coaching, 5 used self-help materials, 1 re-
ported to have used all types of support, 4 reported to
have received the combination of nicotine replacement/
pharmacological support and counseling/coaching or
self-help, and 167 indicated to not have used any of sup-
port. To check whether the respondents in the Act con-
dition and the control condition differed in the support
they had received, the categories were recoded into one
dichotomous variable: no support (n = 167) versus any
support (n = 40). A Chi-square analysis showed that that
the difference was significant, X [2] (1, N = 208) = 13.15,
p < .001: 7.9% of the respondents in the Act condition
received support, against 28% in the control condition.
In the Act condition, only 2 respondents used nicotine
replacement/pharmacological support.
Analyses in respondents
Comparability and matching in respondents
The baseline comparability of respondents in the Act con-
dition and the control condition was tested using the
above 14 variables that could be related to smoking
abstinence. Using univariate analyses (ANOVA for con-
tinuous variables and Chi-square for categorical variables),
there were significant differences only on the affective
pros of smoking, F(224,1) = 5.44, p = .021, and on self-
efficacy with regard to social situations, F(224,1) = 5.81,p = .017: Smokers in the ACt condition scored higher on
the affective pros (ACt condition M= 3.87 (SD = 0.76);
control condition 3.61 (SD (0.89)), and higher on the mea-
sure of self-efficacy (ACt condition M= 4.56 (SD = 1.28);
control condition M= 4.13 (SD (1.4)). Thus, smokers in
the control condition were less psychologically dependent
but had also less confidence that they would be able to quit
smoking.
To increase the comparability of the conditions, a
matching procedure was applied in which the 10% re-
spondents with the most extreme scores were removed
from the control condition, leading to the following de-
cision. To increase the mean affective dependence of the
control condition, the smokers with the lowest 10%
scores on the affective pros were removed. In addition,
to increase the mean level of confidence, the smokers
with the lowest 10% scores on the affective pros were re-
moved. This left 114 respondents in the control condi-
tion (against the 95 in the ACt condition). After this
selection the univariate analyses were run again. Now
there were no significant differences left among the
continuous variables, with the smallest p-value being .14,
and the multivariate analysis including all continuous
baseline variables together showing a F-value below 1
and a p-value of .80. Also with regard to the two cate-
gorical variables (level of education and gender), the
condition did not differ significantly (p-values > .11).
The conclusion is that smokers in the ACt condition
and the control condition are similar now and are com-
parable (Table 1).
Main analyses in respondents
The smokers in the ACt condition (n = 95) and the above
selected smokers in the control condition (n = 114) were
included in the main analyses of testing the difference
between both conditions on the self-reported continuous
abstinence after 13 months. The percentages of smokers
Table 1 Baseline comparability of the smokers in the ACt
condition and in the control condition after applying the
matching procedure in respondents
Variable ACt condition Control condition p-value
Gender, female 50.9% 40% .12




M (SD) M (SD)
Age 44.4 (8.59) 45.4 (14.1) .55
Number of cigarettes 16.5 (6.57) 15.9 (8.97) .58
FTND 3.87 (2.09) 3.74 (2.37) .66
Pros of quitting
Long term 2.18 (0.82) 2.16 (0.84) .86
Short term 2 (0.67) 1.99 (0.69) .91
Social 1.79 (0.94) 1.62 (0.97) .20
Self-evaluative 1.66 (0.67) 1.69 (0.82) .83
Pros of smoking
Cognitive 3.44 (0.73) 3.31 (0.75) .22
Affective 3.87 (0.76) 3.75 (0.77) .26
Self-efficacy situations
Social 4.56 (1.28) 4.31 (1.23) .14
Emotional 4.18 (1.39) 4 (1.47) .38
Habitual 4.93 (1.3) 4.66 (1.41) .16
Note: Due to missing values, the number of smokers in the ACt condition
varied from 93 to 95 and in the control condition from 112 to 114. Univariate
analysis of variance was used to test condition differences; only for gender
and level of education Chi-square analyses were applied.
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condition and 9.6% in the control condition. To test
whether this difference was significant, a logistic re-
gression analysis with condition as the central predictor
and continuous abstinence as dependent variable was con-
ducted. This analysis showed that in the ACt condition
significantly more smokers were abstinent, Exp(B) = 6.52,
95% CI 3.1-13.72; p < .001. To further ascertain that the
14 variables that were used to compare the conditions on
were not responsible for the significance, the same analysis
was run in the same matched selection, now controlling
for these 14 variables. The effect of condition remained
significant, Exp(B) = 9, 95% CI 3.67-22.07; p < .001.
All-cases analyses
Comparability and matching
In the all-cases analyses, all drop outs were considered
to not be abstinent at T3 [19]. This led to percentages of
abstinence in the ACt condition (n = 124) of 31.5% and
in the control condition (n = 161) of 7.5%. Next, the
baseline comparability of the smokers in both conditionsin this sample was investigated. When comparing both
conditions on the 14 variables it seemed that smokers in
the control condition scored significantly higher on
affective pros of smoking, and significantly lower on self-
efficacy in social situations, as well as on social pros of
quitting. To increase the comparability of the control con-
dition, the smokers with the lowest 10% scores on the
affective pros, social self-efficacy and social pros were re-
moved, leaving 121 T1 smokers in the control condition.
The percentage of abstinence in the ACt condition
remained 31.5%, against 8.3% in the control condition.
Main analyses all-cases
The logistic regression analysis with condition as the cen-
tral predictor and continuous abstinence as dependent
variable shows that in the ACt significantly more smokers
were abstinent, Exp(B) = 5.09, 95% CI 2.41-10.78; p < .001.
To ascertain that the above variables in the comparability
analyses were not responsible for the significance, the
same analysis was run in the same matched selection, now
controlling for these variables. The effect of condition




Of the 95 smokers in the ACt condition, 39 reported con-
tinuous abstinence at T3. The aim was to verify these
self-reports with a CO-validation measure. The actual
validation procedure took place between 1 and 4 weeks
after the self-report of abstinence. We were able to con-
duct the validation procedure in 30 of the 39 self-reported
abstinent respondents in the ACt. Of the nine missing,
three could not be contacted because they were on holi-
day, three could not be scheduled at a work location that
we visited (for example, because they drove a truck and
had no office), two did not respond to our e-mails or tele-
phone calls, and one reported that he started smoking again
after the self-report of abstinence some weeks ago.
Of the 30 that followed the validation procedure, one
person reported right beforehand to have started to smoke
again after the self-report of abstinence some weeks ago.
In the remaining 29 respondents, all CO-scores were
7 ppm or lower: two respondents had a CO level of
7 ppm, three had a level of 6 ppm, and all others had
levels of 5 ppm and lower. Thus, in these 29 respondents
who (still) claimed abstinence, abstinence was verified
using the cut-off point of 10 ppm.
Main analyses CO validated abstinence
The above reported logistic regression analyses to test
the differences in proportions of abstinent smokers were
now repeated in the matched groups of respondents
while treating the 9 self-reported abstinent respondents
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tion n = 95; control condition = 114). Thus, for this pur-
pose their self-report of abstinence was considered to be
false.
Analyses in the respondents now showed 31.6% ab-
stainers in the ACt condition and 9.6% in the control
condition, while the logistic regression analysis showed
that the difference was significant, Exp(B) = 4.73, 95% CI
2–11.19; p < .001. The all-cases analysis now showed
percentages abstinence in the ACt and the control condi-
tion (ACt condition n = 124; control condition = 161) of
24.2% and 7.5%, respectively. The logistic regression ana-
lysis still showed a significant difference, Exp(B) = 3.81,
95% CI 1.72-8.47; p = .001. Including the covariates in
these logistic regression analyses did not change the levels
of significances.
Discussion
The present quasi-experimental design showed whether
it is fruitful to expose smokers “in companies to the
ACt”. Thus, the treatment package of “ACt in com-
panies” was tested. All statistical analyses on the dif-
ferences between both conditions on the percentages of
self-reported continuous abstinence were significant,
even the most conservative. The percentage continuous
abstinence in the ACt condition ranged from 24.2% to
41.1% depending on the assumptions and on the selec-
tions of participants, and ranged from 7.5% to 9.6% in
the control condition. When the Exp(B) is interpreted as
an Odds Ratio, smokers following the ACt in their com-
pany were about 6 times more likely to have quit smo-
king after 13 months compared to similar smokers in
the general population.
The value of the results crucially depends on the com-
parability of the smokers in both conditions. When the
smokers were not similar, differences in smoking cessation
might be caused by these existing differences and not by
the ACt. To study comparability, we included three types
of variables that might be relevant for smoking cessation:
Demographic variables, smoking behavior, and psycho-
logical determinants of smoking cessation. The main ana-
lyses were significant when these variables were taken into
account. Therefore, the next question is: “Did we miss any
differences between the smokers in both conditions that
might be responsible for the effect?”. In other words, is it
plausible that one or more not detected differences
between the smokers in the conditions can explain the
differences in percentages abstainers?
Not all possible smoking and quitting history variables
were assessed. The number of past quit attempts and
the duration of the longest quit attempt were not
assessed although they are related to smoking cessation
success [20]. However, one pathway through which past
behavior influences future behavior is through shapingpeople’s perception regarding the behavior [21]. The
most important perceptions regarding smoking cessation
were taken into account in our study in the pros of
smoking, the pros of quitting and self-efficacy. A mea-
sure of smoking history that was not assessed was the
number of years smoked, as a proxy of the duration of
the experience with smoking. However, because most
smokers start to smoke regularly between the ages of 14
and 18 [22-24], age and number of years smoked are
strongly associated. Therefore, statistically controlling
for age should have largely controlled for the number of
years smoked. Also, the age of starting to smoke was not
assessed. A large survey among youngsters [25] suggests
that those who start at younger age are more likely to
become regular and heavy smokers. However, we argue
that in our analyses regularity and heaviness of smoking
was taken into account by the measures of number of
cigarettes smoked a day and the FTND scores. All in all,
it cannot be completely ruled out here that differences
between the conditions in smoking history and quitting
history influenced the results.
A psychological variable that was not included was the
intention to quit: It may have been that smokers in the
ACt and the control group differed in intention to quit.
We omitted intention for the following reason: Within the
context of the ACt being offered to smokers in companies,
with its resulting constraints, the pretest measurement
could only be conducted in the ACt participants after they
were informed that they would actually join the ACt. This
anticipation especially would have biased assessments of
the readiness or intention to quit, disturbing the actual
comparability with the control group. However, we did
assess the motivation to quit with a well validated measure
(with the pros of quitting scales) that includes different
aspects of the motivation and that is probably not suscep-
tible to such a bias (i.e., smokers are not expected to see
more positive effects of quitting when they know they
would join the ACt). The conditions were similar on this
baseline measure.
In conclusion, the most relevant variables were taken
into account in comparing the similarity of the ACt
smokers and the smokers in the control condition, and we
think that it is plausible that the most obvious difference
between the conditions that is designed and expected to
lead to abstinence - the ACt - is responsible for the large
or robust differences in percentage of abstinence. More-
over, almost 30% of the respondents in the control condi-
tion indicated to have received smoking cessation support,
including nicotine replacement, coaching or self-help
materials. This suggests that smokers in the control con-
dition were also engaged in quitting, and were not only in-
terested in joining research or receiving the financial
rewards. However, we cannot rule out that having agreed
to attend a specific smoking cessation intervention (i.e.,
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dition. Thus, some uncertainty remains about the simi-
larity and, therefore, about the effectiveness of the ACt.
It is unclear what exactly may have caused the smo-
kers to quit in the ACt. It is plausible that the one-
session expectancy challenge, which comprises the core
of the ACt, caused smokers to quit: The expectancy
challenge has been shown to have change potential in
lowering alcohol use [6-8]. However, other aspects of the
package of “ACt in companies” that might be responsible
for the effects are the training taking place: 1) in a com-
pany context and; 2) in groups. With regard to the latter,
a recent (uncontrolled) study on the effects of a one-
session large group smoking cessation intervention of
different content - cognitive behavior therapy plus
pharmacotherapy advice - showed promising results
[26]. This suggests that the one-session format can be
sufficient to induce change. Future studies might dis-
mantle the treatment package that was tested in the
present study.
One relevant shortcoming of the CO-validation is that
it only can reliably assess smoking during the past
24 hours, while the self-reported continuous abstinence
that it was supposed to validate referred to having
refrained from smoking for over a year. Future studies
might want to further validate such long term conti-
nuous abstinence self-reports, although at present there
is no ideal way to do so.
Conclusions
It is plausible that the differences in percentages abstainers
in the conditions can be attributed to the ACt provided in
companies. Moreover, in our view it is less plausible that
the large or robust differences can be explained by factors
we did not assess. In addition, the expectancy challenge
strategy that comprises the main ingredient of the ACt
has been shown to be effective in reducing alcohol
consumption, strongly suggesting that it has potential to
induce behavior change. In conclusion, the present study
reveals relevant clues that providing smokers with the
package of ACt in companies can be an effective smoking
cessation strategy, although uncertainties inherent to the
quasi-experimental design remain.
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